Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients

Surgery Today

Volumn 42, Issue 3, 2012, Pages 245-249

  Sasada, Tatsunari ^a,b   Murakami, Shigeru ^b   Kataoka, Tsuyoshi ^b   Ohara, Masahiro ^b   Ozaki, Shinji ^b   Okada, Morihito ^b   Ohdan, Hideki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Axillary lymph node dissection; Breast cancer; Metastasis; Nomogram; Sentinel lymph node biopsy

Indexed keywords

ACCURACY; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; JAPANESE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOMOGRAM; ONLINE MONITORING; PATIENT IDENTIFICATION; PREDICTION; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; VALIDATION STUDY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; JAPAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NOMOGRAMS; RECEPTORS, ESTROGEN; RISK ASSESSMENT; ROC CURVE; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL;

EID: 84857650908     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-011-0088-2     Document Type: Article

References (23)

1. U Veronesi G Paganelli V Galimberti G Viale S Zurrida M Bedoni, et al. 1997 Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet 349 1864 1867 9217757 10.1016/S0140-6736(97)01004-0 1:STN:280:DyaK2szmtVOqtg%3D%3D (Pubitemid 27270119)
2. H Iwase Y Yamamoto T Kawasoe M Ibusuki 2009 Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment Surg Today 39 374 380 19408073 10.1007/s00595-008-3880-x
3. RR Turner DW Ollila DL Krasne AE Giuliano 1997 Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma Ann Surg 226 271 276 9339933 10.1097/00000658-199709000-00006 1:STN:280:DyaK2svnvFymsA%3D%3D discussion 76-8 (Pubitemid 28070919)
4. KU Chu RR Turner NM Hansen MB Brennan A Bilchik AE Giuliano 1999 Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229 536 541 10203087 10.1097/00000658- 199904000-00013 1:STN:280:DyaK1M3hslOgtQ%3D%3D (Pubitemid 30191752)
5. AE Giuliano PI Haigh MB Brennan NM Hansen MC Kelley W Ye, et al. 2000 Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer J Clin Oncol 18 2553 2559 10893286 1:STN:280:DC%2BD3czlt1Snug%3D%3D (Pubitemid 30432521)
6. B Unal AS Gur O Kayiran R Johnson G Ahrendt M Bonaventura, et al. 2008 Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system Int J Clin Pract 62 1785 1791 19143863 10.1111/j.1742-1241.2008.01887.x 1:STN:280: DC%2BD1M%2Fnt1Wgsg%3D%3D
7. KJ Van Zee DM Manasseh JL Bevilacqua SK Boolbol JV Fey LK Tan, et al. 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 1140 1151 14654469 10.1245/ASO.2003.03.015 (Pubitemid 40486808)
8. ML Smidt DM Kuster GJ van der Wilt FB Thunnissen KJ Van Zee LJ Strobbe 2005 Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 12 1066 1072 16244802 10.1245/ASO.2005.07.022 (Pubitemid 41660683)
9. AC Degnim C Reynolds G Pantvaidya S Zakaria T Hoskin S Barnes, et al. 2005 Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram Am J Surg 190 543 550 16164917 10.1016/j.amjsurg.2005.06.008 (Pubitemid 41306072)
10. R Ponzone F Maggiorotto L Mariani ME Jacomuzzi A Magistris P Mininanni, et al. 2007 Comparison of two models for the prediction of nonsentinel node metastases in breast cancer Am J Surg 193 686 692 17512277 10.1016/j.amjsurg. 2006.09.031 (Pubitemid 46745283)
11. A Pal E Provenzano SW Duffy SE Pinder AD Purushotham 2008 A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive Br J Surg 95 302 309 17876750 10.1002/bjs.5943 1:STN:280:DC%2BD1c7islSgtw%3D%3D
12. J Zgajnar A Perhavec M Hocevar M Podkrajsek K Hertl S Frkovic-Grazio, et al. 2007 Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients J Surg Oncol 96 547 553 17708546 10.1002/jso.20835 (Pubitemid 350191478)
13. LA Lambert GD Ayers RF Hwang KK Hunt MI Ross HM Kuerer, et al. 2006 Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy Ann Surg Oncol 13 310 320 16463073 10.1245/ASO.2006.03.078 (Pubitemid 43255913)
14. MH Cripe LC Beran WC Liang BJ Sickle-Santanello 2006 The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram Am J Surg 192 484 487 16978955 10.1016/j.amjsurg.2006.06.016 (Pubitemid 44344193)
15. S Alran Y De Rycke V Fourchotte H Charitansky F Laki MC Falcou, et al. 2007 Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy Ann Surg Oncol 14 2195 2201 17294071 10.1245/s10434-006-9331-2 (Pubitemid 47174905)
16. HE Kohrt RA Olshen HR Bermas WH Goodson DJ Wood S Henry, et al. 2008 New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients BMC Cancer 8 66 18315887 10.1186/1471-2407-8-66 (Pubitemid 351566658)
17. RF van la Parra MF Ernst JL Bevilacqua SJ Mol KJ Van Zee JM Broekman, et al. 2009 Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram Ann Surg Oncol 16 1128 1135 10.1245/s10434-009-0359-y
18. EF Schisterman D Faraggi B Reiser M Trevisan 2001 Statistical inference for the area under the receiver operating characteristic curve in the presence of random measurement error Am J Epidemiol 154 174 179 11447052 10.1093/aje/154.2.174 1:STN:280:DC%2BD3Mzpt1GksA%3D%3D (Pubitemid 32643134)
19. JE Fischer LM Bachmann R Jaeschke 2003 A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis Intensive Care Med 29 1043 1051 12734652 10.1007/s00134-003-1761-8 (Pubitemid 36918544)
20. JA Olson Jr LM McCall P Beitsch PW Whitworth DS Reintgen PW Blumencranz, et al. 2008 Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011 J Clin Oncol 26 3530 3535 18640934 10.1200/JCO.2007.15.5630
21. VJ Kamath R Giuliano EL Dauway A Cantor C Berman NN Ku, et al. 2001 Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection Arch Surg 136 688 692 11387010 10.1001/archsurg.136.6.688 1:STN:280:DC%2BD3MzlvVersA%3D%3D (Pubitemid 32525473)
22. KR Bauer M Brown RD Cress CA Parise V Caggiano 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 1721 1728 17387718 10.1002/cncr.22618 (Pubitemid 46668532)
23. E Poirier L Sideris P Dube P Drolet SH Meterissian 2008 Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the Canadian experience Ann Surg Oncol 15 2562 2567 18618183 10.1245/s10434-008-0033-9